Status:
COMPLETED
Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy
Lead Sponsor:
University Hospital, Saarland
Conditions:
Electric Stimulation Therapy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Intensive chemotherapy, with or without following autologous or allogeneic stem cell transplantation (HSCT), is often the only curative treatment option for patients with haematological malignancies, ...
Eligibility Criteria
Inclusion
- 18 - 80 years of age
- ECOG mperformance status 0-2
- patients undergoing chemotherapy regimens and and expected hospitalization time of \> 14 days
Exclusion
- patients with pacemakers and defibrillators
- patients with metallic implants close to stimulation sites
- skin irritations and injuries at the site of electrode placement
- pregnancy
- epilepsy
- patient is physically or mentally unable to administer EMS by him/her -self
- history of ventricular arrhythmias
- peripheral arterial disease
- deep vein thrombosis in the past 3 month
- myocardial infarction or stroke in the past 3 month
Key Trial Info
Start Date :
February 3 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03467087
Start Date
February 3 2016
End Date
March 16 2017
Last Update
March 15 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.